Analysis and comparison of drug safety supervision and high-quality development planning policies of the governments of all provinces ( autonomous regions and province-level municipalities) during the"14th Five-Year Plan"periodHE Hui, TANG Xiang-yan, ZHOU Gang1385-1391
The application of qualitative research and mixed methods research in patient involvement in drug developmentCHU Hong-ling, XU Yan, HAN Sheng, ZHAO Li-bo, LI Nan, TAO Li-yuan, ZENG Lin, ZHUO Lin, CHEN Ya-hong, ZHAO Yi-ming, LI Hai-yan, ZHAN Si-yan1392-1397
Development and trends of corporate venture capital in pharmaceutical industryYANG Shu-jun, PANG Bo-wen, ZHOU Bin1398-1405
Setting of the run-in period and its application in clinical trialsHAN Fang, LIU Bao-li, CAO Ke-gang, GAO Ying1406-1410
The implementation process of simulation technology in clinical trials and case practiceLI Ruo-bing, WANG Jing-zhao, WANG Jun1411-1416
Research progress in flavor correction and mask technology for traditional Chinese medicine oral liquids for childrenMA Si-wen, MENG Ya, CHE Hong-wei, JIN Li-qun, HE Shu-wang, WANG Hui, TAN Xiao-chuan, ZHANG Yu-jia, JIAO Yang, ZHENG Wen-sheng1417-1422
Establishment and validation of a biological activity detection method for adalimumabJIA Zhe, GUO Sha, WANG Wen-bo, YANG Ya-lan, LONG Cai-feng, WANG Lan, LIU Wan-hui1423-1431
Research progress in procyanidins for the prevention and treatment of central nervous system degenerative diseasesYAO Zi-meng, CHEN Lei, SUN Xiao-rong, HUANG Jie, DONG Shu-ying1432-1437
Research progress in nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome in depressionGUO Xin-lei, GAO Ming-qi, QIN Yu1438-1445
Research progress in anti-inflammatory effect of plant volatile oilXIAO Jia-huan, DONG Wei, HUANG Xiao-ying, LIANG Xin-li, QIAN Xing-yi1446-1451